TTTS affects 10–15% of monochorionic twin pregnancies and is associated with increased perinatal mortality and morbidity (Berghella & Kaufmann, Reference Berghella and Kaufmann2001). If untreated, it leads to fetal demise in up to 90% of cases, with morbidity rates in survivors of over 50% (Roberts et al., Reference Roberts, Gates, Kilby and Neilson2008; Reference Roberts, Neilson, Kilby and Gates2014). Early diagnosis, however, may allow intervention with fetoscopic laser ablation, which significantly improves the prognosis. Laser treatment in these pregnancies results in 60–70% double survival and 80–90% of women being able to take home at least one baby (Baschat et al., Reference Baschat, Barber, Pedersen, Turan and Harman2013; Roberts et al., Reference Roberts, Neilson, Kilby and Gates2014).
While the exchange of blood between the twins through placental vascular anastomoses is quite common in these pregnancies, it is the imbalance in the degree of transfusion that leads to the development of TTTS. TTTS is currently classified using the Quintero staging system (Quintero et al., Reference Quintero, Morales, Allen, Bornick, Johnson and Kruger1999; Reference Quintero, Dickinson, Morales, Bornick, Bermúdez, Cincotta and Allen2003). It has been questioned whether stage I TTTS truly represents the first in a chronological series of stages of deterioration, and suggested that it might not predict survival well after treatment. While incorporation of additional cardiovascular parameters stratifies additional disease features independent of the Quintero staging, these do not improve prediction of outcome following treatment. Nevertheless, the Quintero staging system remains the most commonly used for the classification of twin pregnancies complicated by TTTS.
Despite the fact that the Eurofetus trial has demonstrated clear superiority of fetoscopic laser ablation over amnioreduction in the treatment of severe TTTS, only 11 pregnancies were stage 1 TTTS, hindering any meaningful statistical subanalyses (Senat et al., Reference Senat, Deprest, Boulvain, Paupe, Winer and Ville2004). Furthermore, the natural history of stage 1 TTTS is unclear. Studies have reported controversial rates of progression in stage 1 TTTS, from as low as 10% (Bebbington et al., Reference Bebbington, Tiblad, Huesler-Charles, Wilson, Mann and Johnson2010) to as high as 45–50% (Dickinson & Evans, Reference Dickinson and Evans2004; Duryea et al., Reference Duryea, Happe, McIntire and Dashe2016). For these reasons, the optimal treatment of stage 1 TTTS is yet to be established. Many centers manage Quintero stage I conservatively. Older studies have advocated the use of amnioreduction as an acceptable treatment in these cases (Bebbington et al., Reference Bebbington, Tiblad, Huesler-Charles, Wilson, Mann and Johnson2010; Dickinson & Evans, Reference Dickinson and Evans2004; Taylor et al., Reference Taylor, Denbow, Duncan, Overton and Fisk2000), and more recent studies have used laser, either in progressive cases or as a first-line treatment (Chmait et al., Reference Chmait, Kontopoulos, Korst, Llanes, Petisco and Quintero2011; Huber et al., Reference Huber, Diehl, Bregenzer, Hackelöer and Hecher2006; Quintero et al., Reference Quintero, Dickinson, Morales, Bornick, Bermúdez, Cincotta and Allen2003; Wagner et al., Reference Wagner, Lopriore, Klumper, Oepkes, Vandenbussche and Middeldorp2009).
In a systematic review of the management of stage 1 TTTS, the overall survival appeared to be similar for laser therapy and conservative management (85% and 86% respectively), but somewhat lower for amnioreduction (77%; Rossi & D'Addario, Reference Rossi and D'Addario2013). Of note, this review included seven articles, searched the literature between 1999 and 2011, and assessed the progression even in those pregnancies undergoing intervention, that is, amnioreduction or laser, and did not perform meta-analysis or assessment of the quality of the included studies (Rossi & D'Addario, Reference Rossi and D'Addario2013). The main aims of this meta-analysis were to quantify the incidence of progression in stage 1 TTTS and to ascertain survival in these pregnancies.
Methods
Protocol, Eligibility Criteria, Information Sources, and Search
This review was performed according to a protocol designed a priori and recommended for systematic reviews and meta-analysis (Henderson et al., Reference Henderson, Craig, Willis, Tovey and Webster2010; NHS Centre, 2009; Stroup et al., Reference Stroup, Berlin, Morton, Olkin, Williamson, Rennie and Thacker2000). MEDLINE (1946–January 2016), EMBASE (1947–January 2016) and The Cochrane Library (since inception) including The Cochrane Database of Systematic Reviews (CDSR), Database of Abstracts of Reviews of Effects (DARE) and The Cochrane Central Register of Controlled Trials (CENTRAL) were searched electronically on January 27, 2016, utilizing combinations of the relevant MeSH terms, key words, and word variants for ‘TTTS’, ‘progression’, ‘stage’, ‘survival’, ‘fetal loss’ (Supplementary Table 1). The search was restricted to the English language. Reference lists of relevant articles and reviews were hand searched for additional reports. The MOOSE guidelines were followed (Stroup, Reference Stroup, Berlin, Morton, Olkin, Williamson, Rennie and Thacker2000). The study was registered with the PROSPERO database (Registration number: CRD CRD42016036190, http://www.crd.york.ac.uk/PROSPERO).
Study Selection, Data Collection, and Data Items
Studies were assessed according to the following criteria: population, outcome, study design, and prenatal intervention. Studies reporting the incidence of progression or the survival rate in twin pregnancies complicated by Quintero stage 1 TTTS were included. The diagnosis of TTTS relied on the standard criteria of oligohydramnios in the donor's sac (maximal vertical pocket ≤2 cm) and polyhydramnios in the recipient's sac (maximal vertical pocket ≥8 cm). The Quintero staging system was proposed to assess the severity of TTTS using the following criteria: stage I: visualization of donor's bladder; stage II: bladder not visualized in the donor twin; stage III: abnormal Doppler of the umbilical artery and/or ductus venosus in one or both twins; stage IV: hydrops in one or both twins; stage V: intrauterine demise of one or both twins (Quintero et al., Reference Quintero, Morales, Allen, Bornick, Johnson and Kruger1999). Cases were excluded if they were treated with selective feticide or the survival rates were not stratified by TTTS stages.
All abstracts were reviewed independently by two authors. Agreement about potential relevance was reached by consensus, and full text copies of those papers were obtained. The same two reviewers independently extracted data regarding study characteristics and outcomes. Inconsistencies were discussed by the reviewers and consensus reached. For those articles in which information was not reported but the methodology was such that this information would have been recorded initially, the authors were contacted. If more than one study was published for the same cohort with identical endpoints, the report containing the most comprehensive information on the population was included to avoid overlapping populations.
The outcomes observed in this systematic review were the incidence of progression and the survival. Progression was defined as an increase in stage (from stage 1 to stage 2 or higher) or progressing polyhydramnios with a shortening cervix, and was assessed in the pregnancies that were managed expectantly. The survival included the overall survival, double survival (both twins survived) and at least one survival (at least one twin survived). Randomized controlled trials, prospective and retrospective cohort, case-control studies and case series with more than three twin pregnancies complicated by Quintero stage 1 TTTS were included. Case reports, conference abstracts, and editorials were excluded.
Risk of Bias, Summary Measures, and Synthesis of the Results
Quality of the included studies was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology statement criteria (Stroup, Reference Stroup, Berlin, Morton, Olkin, Williamson, Rennie and Thacker2000). We used random-effect meta-analyses of proportions to combine data (Hunter et al., Reference Hunter, Saratzis, Sutton, Boucher, Sayers and Bown2014; Manzoli et al., Reference Manzoli, De Vito, Salanti, D'Addario, Villari and Ioannidis2011). The survival was analyzed according to the intervention received, including conservative management, amnioreduction, and endoscopic laser photocoagulation. Between-study heterogeneity was assessed using the I2 statistic (Higgins et al., Reference Higgins, Thompson, Deeks and Altman2003). Publication bias was explored using funnel plots and was assessed statistically using the Egger test (which uses the actual values of the effect sizes and their precision, rather than ranks; Sterne & Egger, Reference Sterne and Egger2001). The assessment of the potential publication bias was problematic because of the low number of individual studies, which strongly limits the reliability of formal tests. Funnel plots displaying the outcome rate from individual studies versus their precision (1/standard error) were carried out with an exploratory aim. Tests for funnel plot asymmetry were not used when the total number of publications included for each outcome was less than 10. In this case, the power of the tests is too low to distinguish chance from real asymmetry (Higgins & Green, Reference Higgins and Green2009).
Statistical analyses were performed using Stats Direct (Version 2.7.8, Stats Direct Ltd, 9 Bonville Chase, Altrincham, Cheshire WA14 4QA, UK) statistical software.
Results
The search yielded 3,085 citations; of these, 3,052 were excluded by review of the title or abstract, as they did not meet the selection criteria, contain original data, were not relevant, contained data on three cases or less, or had data which were included in another study (Figure 1). Full manuscripts were retrieved for the remaining 33, and a total of 18 studies were included in the review. Seven studies reported data on progression (172 pregnancies with stage 1 TTTS), while data on survival were reported in 16 studies (433 pregnancies with stage 1 TTTS; Figure 1). Table 1 shows the characteristics of the studies included in this systematic review.
FIGURE 1 Flow of study identification.
TABLE 1 Summary of the 18 Studies Included Which Reported Progression or Survival in Twin Pregnancies Complicated by Quintero Stage 1 Twin-To-Twin Transfusion Syndrome (TTTS)
Progression in Twin Pregnancies Complicated by Quintero Stage 1 TTTS
Seven studies reported the incidence of progression in stage 1 TTTS managed expectantly (Bebbington et al., Reference Bebbington, Tiblad, Huesler-Charles, Wilson, Mann and Johnson2010; Dickinson & Evans, Reference Dickinson and Evans2004; Duryea et al., Reference Duryea, Happe, McIntire and Dashe2016; Meriki et al., Reference Meriki, Smoleniec, Challis and Welsh2010; O'Donoghue et al., Reference O'Donoghue, Cartwright, Galea and Fisk2007; Taylor et al., Reference Taylor, Govender, Jolly, Wee and Fisk2002; Wagner et al., Reference Wagner, Lopriore, Klumper, Oepkes, Vandenbussche and Middeldorp2009). The pooled incidence of progression in these pregnancies was 27% [95% CI 16–39%] (Figure 2). The reported rate of progression in the included studies varied from as low as 10% to as high as 50%. The number of pregnancies with stage 1 TTTS reported in these studies ranged between 9 and 46.
FIGURE 2 Pooled incidence (forest plot) of progression in twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome (TTTS). Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Survival in Twin Pregnancies Complicated by Quintero Stage 1 TTTS Managed Expectantly
Four studies (73 pregnancies) reported the survival rates in pregnancies with stage 1 TTTS that were managed expectantly (Bebbington et al., Reference Bebbington, Tiblad, Huesler-Charles, Wilson, Mann and Johnson2010; Luks et al., Reference Luks, Carr, Muratore, O'Brien and Tracy2009; Meriki et al., Reference Meriki, Smoleniec, Challis and Welsh2010; Wagner et al., Reference Wagner, Lopriore, Klumper, Oepkes, Vandenbussche and Middeldorp2009). The pooled overall survival, double survival, and at least one survival were 79% [95% CI 62–92%], 70% [95% CI 54–84%] and 87% [95% CI 69–98%], respectively (Figure 3).The highest survival rate was reported in the study by Meriki et al. (Reference Meriki, Smoleniec, Challis and Welsh2010), which had only 9 pregnancies, while the lowest survival rate was reported in the study by Luks et al. (Reference Luks, Carr, Muratore, O'Brien and Tracy2009) which had 14 pregnancies.
FIGURE 3 Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome (TTTS) managed conservatively. The overall survival (a), double survival, (b) and at least one survival (c) are shown. Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Survival in Twin Pregnancies Complicated by Quintero Stage 1 TTTS Managed by Amnioreduction
Eight studies (147 pregnancies) reported the survival rates in pregnancies with stage 1 TTTS that were managed by amnioreduction (Bebbington et al., Reference Bebbington, Tiblad, Huesler-Charles, Wilson, Mann and Johnson2010; Blaicher et al., Reference Blaicher, Ulm, Ulm, Kuhle, Deutinger and Bernaschek2002; Dickinson & Evans, Reference Dickinson and Evans2004; Fichera et al., Reference Fichera, Lanna, Fratelli, Rustico and Frusca2010; Quintero et al., Reference Quintero, Morales, Allen, Bornick, Johnson and Kruger1999; Tan et al., Reference Tan, Taylor, Wee, Vanderheyden, Wimalasundera and Fisk2004; Taylor et al., Reference Taylor, Govender, Jolly, Wee and Fisk2002). The pooled overall survival, double survival, and at least one survival were 77% [95% CI 68–85%], 67% [95% CI 57–76%] and 86% [95% CI 76–94%], respectively (Figure 4).The highest survival rate was reported in the studies by Blaicher et al. (Reference Blaicher, Ulm, Ulm, Kuhle, Deutinger and Bernaschek2002) and Quintero et al. (Reference Quintero, Dickinson, Morales, Bornick, Bermúdez, Cincotta and Allen2003), which had 13 and 11 pregnancies, respectively. The lowest survival rates were reported by the older study by Quintero et al. (Reference Quintero, Morales, Allen, Bornick, Johnson and Kruger1999) and Taylor et al. (Reference Taylor, Govender, Jolly, Wee and Fisk2002), which had 10 and 13 pregnancies, respectively.
FIGURE 4 Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome (TTTS) managed by amnioreduction. The overall survival (a), double survival (b), and at least 1 survival (c) are shown. Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Survival in Twin Pregnancies Complicated by Quintero Stage 1 TTTS Managed by Endoscopic Laser Photocoagulation
Four studies (51 pregnancies) reported the survival rates in pregnancies with stage 1 TTTS that were managed by laser (Has et al., Reference Has, Kalelioglu, Corbacioglu Esmer, Ermis, Dural, Dogan and Yildirim2014; Müllers et al., Reference Müllers, McAuliffe, Kent, Carroll, Mone, Breslin and Malone2015; Sundberg et al., Reference Sundberg, Søgaard, Jensen, Schou and Jørgensen2012; Wagner et al., Reference Wagner, Lopriore, Klumper, Oepkes, Vandenbussche and Middeldorp2009). The pooled overall survival, double survival, and at least one survival were 68% [95% CI 54–81%], 54% [95% CI 36–72%) and 81% [95% CI 69–90%], respectively (Figure 5). The lowest survival rate was reported by the study by Has et al. (Reference Has, Kalelioglu, Corbacioglu Esmer, Ermis, Dural, Dogan and Yildirim2014), which included 12 pregnancies with stage 1 TTTS. The largest study, by Wagner et al. (Reference Wagner, Lopriore, Klumper, Oepkes, Vandenbussche and Middeldorp2009), included 20 pregnancies and reported a double survival rate of 65%.
FIGURE 5 Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome (TTTS) managed by endoscopic laser photocoagulation. The overall survival (a), double survival (b), and at least 1 survival (c) are shown. Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Survival in Twin Pregnancies Complicated By Quintero Stage 1 TTTS Managed By Endoscopic Laser Photocoagulation as the First-Line Treatment
Three studies (162 pregnancies) reported the survival rates in pregnancies with stage 1 TTTS that were managed by laser as the first-line treatment (Chmait et al., Reference Chmait, Kontopoulos, Korst, Llanes, Petisco and Quintero2011; Huber et al., Reference Huber, Diehl, Bregenzer, Hackelöer and Hecher2006; Quintero et al., Reference Quintero, Dickinson, Morales, Bornick, Bermúdez, Cincotta and Allen2003). The pooled overall survival, double survival, and at least one survival were 84% [95% CI 79–88%], 77% [95% CI 71–83%] and 91% [95% CI 86–95%], respectively (Figure 6). The lowest survival rate was reported by the oldest of the four studies (Quintero et al., Reference Quintero, Dickinson, Morales, Bornick, Bermúdez, Cincotta and Allen2003), which included the smallest number of pregnancies (21 pregnancies with stage 1 TTTS) and reported a double survival rate of 67%. The largest study, by Chmait et al. (Reference Chmait, Kontopoulos, Korst, Llanes, Petisco and Quintero2011), included 112 pregnancies with stage 1 TTTS and reported a double survival rate of 80%.
FIGURE 6 Pooled survival (forest plot) of twin pregnancies complicated by Quintero stage 1 twin-to-twin transfusion syndrome (TTTS) managed by endoscopic laser photocoagulation as first line. The overall survival (a), double survival (b), and at least 1 survival (c) are shown. Each study is represented by a line. The box in the middle of the line represents the point effect estimate of this particular study. The midpoint of the box represents the point effect estimate, that is, the mean effect estimate for each study. The area of the box represents the weight given to the study. The diamond below the studies represents the overall estimate. The width of the line shows the confidence interval (CI) of the effect estimate of individual studies. The width of the diamond shows the CI for the overall effect estimate.
Quality Assessment of the Included Studies
The quality of the studies is summarized in Figure 7. Among the studies included in this review, the title, abstract, study design, eligibility, data variables, data sources, assessment methods, explanation of the quantitative variables, and their analysis, summary of the key findings and the interpretation of the studies were appropriately described in 100%. On the other hand, explanation of study size (sample size calculation) was reported in none, and flow diagrams to describe the study population were rarely used. However, the background, objectives, study setting, recruitment period, and reporting number of outcome events were described in more than 90% of these studies. The statistical methods were adequately described in more than 80% of the studies. Efforts to address bias and acknowledging the limitations of the study were reported in approximately 50% of the studies (Figure 7).
FIGURE 7 Quality criteria of the included articles, as assessed using the Strengthening the Reporting of Observational Studies in Epidemiology checklist.
Discussion
Summary of Findings
The findings of this meta-analysis suggest that the incidence of progression in stage 1 TTTS was 27%. The pooled overall survival was 79%, 77%, 68%, and 84% in stage 1 TTTS managed expectantly, by amnioreduction, laser if there is progression, and laser as first-line treatment, respectively. The corresponding pooled double survival figures were 70%, 67%, 54%, and 77%, respectively. Lastly, the corresponding pooled at least one survival figures were 87%, 86%, 81%, and 91%, respectively.
Interpretation of the Findings
Stage 1 TTTS progresses to a higher stage or more severe polyhydramnios in approximately one quarter of the pregnancies. There is a considerable variation in the incidence of progression reported in the published studies. One potential explanation could be the variation of the criteria for defining progression across the studies. Most of the included studies defined progression as an increase in stage (from stage 1 to stage 2 or higher), so potentially have underestimated the risk of progression.
The survival rates in the various subgroups, according to the management of stage 1 TTTS, do not show marked variation, but suggest that laser surgery as a first-line treatment might be associated with better survival. However, these results should be interpreted with caution as they are derived from observational data with their inherent risk of bias. The survival rates associated with amnioreduction or laser as the management of cases that had progressed, are likely to be worse than those which did not progress, so were managed expectantly, or in those pregnancies where laser surgery was performed, as a first-line treatment.
It is generally accepted that TTTS diagnosed before 26 weeks of gestation is best treated by laser ablation as the evidence suggests that it leads to better outcomes compared with amnioreduction or septostomy (Roberts et al., Reference Roberts, Neilson, Kilby and Gates2014). However, where laser ablation expertise is not available, an acceptable alternative in pregnancies diagnosed after 26 weeks of gestation is amnioreduction (Roberts et al., Reference Roberts, Neilson, Kilby and Gates2014). But there is some evidence that laser ablation is still the best form of treatment for TTTS, even if diagnosed early (before 16 weeks) or late (after 26 weeks’ gestation; Baud et al., Reference Baud, Windrim, Keunen, Kelly, Shah, van Mieghem and Ryan2013; Middeldorp et al., Reference Middeldorp, Lopriore, Sueters, Klumper, Kanhai, Vandenbussche and Oepkes2007).
Clinical and Research Implications of the Review Findings
In view of the risk of progression in approximately one quarter of stage 1 TTTS, these pregnancies require regular weekly monitoring looking for signs of deterioration. This monitoring should include ultrasound assessment of the fetal bladders, Dopplers, severity of polyhydramnios, and cervical length. There is no evidence to date supporting the use any ultrasound or biochemical markers to predict the risk of progression in these pregnancies. Furthermore, in view of the limited predictive ability of the Quintero staging system, management decisions should take into account other known risk factors associated with worse outcome, such as the gestational age at diagnosis and cervical length.
The results of this meta-analysis present evidence that the optimal initial management of stage 1 TTTS remains in equipoise. On one hand, some could argue that three quarters of these cases regress or remain stable, with a survival rate that is far better than that quoted for the untreated cases of severe TTTS (80% overall survival in the group with expectant management vs. 80–90% mortality). On the other hand, it is true that this survival rate might be over-optimistic, as it does not take into account those pregnancies that have progressed and required intervention, or ended in fetal demise, preterm birth and/or neurological impairment. In fact, postponing surgery could arguably increase the rates of spontaneous fetal demise and secondary neurological morbidity, as well as preterm premature rupture of the membranes and very preterm birth. The ongoing international randomized trial comparing the two management strategies, immediate percutaneous laser surgery versus conservative management, in stage 1 TTTS should provide a definitive answer to this question.
Strengths and Limitations of the Meta-Analysis
The strengths of this meta-analysis are the a priori designed protocol following the recommended guidelines for systematic reviews and meta-analysis of observational studies, the thorough literature search, the assessment of the quality of the included studies, the quantitative synthesis of evidence, and the relatively large number of included articles and pregnancies with stage 1 TTTS, which occurs in a minority of TTTS cases. The quality of the data available for meta-analysis limits the current study findings. Small retrospective observational studies and selection bias were the main drawbacks. This meta-analysis reported on the survival, rather than intact survival, in stage 1 TTTS. This reflects the limited reported data on intact survival in these pregnancies. When reported, expectant management seems to be associated with worse short- and long-term neurodevelopmental outcomes than those pregnancies treated with laser (Wagner et al., Reference Wagner, Lopriore, Klumper, Oepkes, Vandenbussche and Middeldorp2009). Moreover, the survival rates in these pregnancies are influenced by a number of risk factors, such as the gestational age at diagnosis as well as at treatment, birthweight discordance, type of inter-twin vascular anastomoses, and placental territory. Unfortunately, these variables are not reported in the majority of the published studies, and furthermore, such analysis would require individual participant data (IPD) instead of aggregate data meta-analysis, in order to adjust for these potential confounders.
Large, multicenter randomized controlled trials are required to improve the robustness of the results, and target intact survival that takes into account the neurodevelopmental outcome of the infants. Prospective national collection of data on twin pregnancies with stage 1 TTTS, their management and outcomes would be a valuable source while waiting for the results of the RCT.
Conclusion
Progression occurred in 27% of pregnancies with stage 1 TTTS. The overall survival was 79%, 77%, 68%, and 84% in stage 1 TTTS managed expectantly, by amnioreduction, laser surgery if there is progression, and laser as first-line treatment, respectively. The optimal initial management of stage 1 TTTS remains in equipoise. The ongoing randomized trial comparing immediate laser surgery versus conservative management in stage 1 TTTS should provide a definitive answer to this question. Meanwhile, prospective national collection of data on these pregnancies, their management and outcomes are needed.
Acknowledgments
We would like to acknowledge the following authors for their help in clarifying the data in the studies: Dr Sienglinde Mullers; Dr Elaine Duryea; Dr Tony Tan and Professor Nick Fisk; Dr Recep Has; Dr Ramen Chmait.
Supplementary Material
To view supplementary material for this article, please visit http://dx.doi.org/10.1017/thg.2016.33.
